A double-blind, placebo-controlled, multicenter trial of adjunctive armodafinil for the treatment of major depression associated with bipolar I disorder
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1552
https://www.valueinhealthjournal.com/article/S1098-3015(13)01623-9/fulltext
Section Title :
Mental Health
Section Order :
1267
First Page :
A55
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01623-9&doi=10.1016/j.jval.2013.03.1552